Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-021867
Filing Date
2020-08-13
Accepted
2020-08-13 16:08:03
Documents
61
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_chinapharmaholdings.htm 10-Q 333168
2 CERTIFICATION f10q0620ex31-1_chinapharma.htm EX-31.1 8678
3 CERTIFICATION f10q0620ex31-2_chinapharma.htm EX-31.2 8873
4 CERTIFICATION f10q0620ex32-1_chinapharma.htm EX-32.1 5062
  Complete submission text file 0001213900-20-021867.txt   2439498

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cphi-20200630.xml EX-101.INS 320142
6 XBRL SCHEMA FILE cphi-20200630.xsd EX-101.SCH 38028
7 XBRL CALCULATION FILE cphi-20200630_cal.xml EX-101.CAL 58417
8 XBRL DEFINITION FILE cphi-20200630_def.xml EX-101.DEF 83626
9 XBRL LABEL FILE cphi-20200630_lab.xml EX-101.LAB 253516
10 XBRL PRESENTATION FILE cphi-20200630_pre.xml EX-101.PRE 191492
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 201099355
SIC: 2834 Pharmaceutical Preparations